As of 2026-08-24, Revvity, Inc. (RVTY) has a 3-month relative strength percentile of 86 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.4%, relative volume 0.94×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
RVTY is in a stage 2 uptrend, week 8. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 10.2% / 22.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
RVTY is held by 46 ETFs as of May 2026. Top owner: VHT at 0.19% weight, $36M notional. Top 3 carry $80M.
Held by 156 ETFs · $2.0B across latest filings · largest weight 2.22% (NBSM).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.19% | $36M | +0.02 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.22% | $32M | — |
| SCHXSchwab U.S. Large-Cap ETF | 0.02% | $13M | — |
| SPHBInvesco S&P 500 High Beta ETF | 0.87% | $9M | new |
| FNDX |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.03% |
| $8M |
| — |
| VONVVanguard Russell 1000 Value ETF | 0.04% | $8M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.02% | $7M | — |
| ESML | 0.28% | $7M | — |
| SCHVSchwab U.S. Large-Cap Value ETF | 0.04% | $6M | — |
| NBSM | 2.22% | $5M | +0.92 pp |
Showing 10 of 46 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RVTY Jan avg: 7.84% median: 12.46% win: 67% σ: 8.48% n: 3 2023-05-17 → 2026-07-31 | RVTY Feb avg: -6.16% median: -9.64% win: 33% σ: 7.32% n: 3 2023-05-17 → 2026-07-31 | RVTY Mar avg: -6.91% median: -5.66% win: 0% σ: 3.52% n: 3 2023-05-17 → 2026-07-31 | RVTY Apr avg: -5.08% median: -2.41% win: 0% σ: 5.76% n: 3 2023-05-17 → 2026-07-31 | RVTY May avg: 6.27% median: 3.80% win: 75% σ: 10.43% n: 4 2023-05-17 → 2026-07-31 | RVTY Jun avg: 3.09% median: 4.71% win: 75% σ: 5.06% n: 4 2023-05-17 → 2026-07-31 | RVTY Jul avg: 3.83% median: 2.32% win: 75% σ: 11.97% n: 4 2023-05-17 → 2026-07-31 | RVTY Aug avg: -1.58% median: -2.44% win: 33% σ: 3.74% n: 3 2023-05-17 → 2026-07-31 (current) | RVTY Sep avg: -1.30% median: -2.73% win: 33% σ: 4.99% n: 3 2023-05-17 → 2026-07-31 | RVTY Oct avg: -8.52% median: -7.17% win: 33% σ: 16.01% n: 3 2023-05-17 → 2026-07-31 | RVTY Nov avg: 5.60% median: 7.30% win: 67% σ: 6.97% n: 3 2023-05-17 → 2026-07-31 | RVTY Dec avg: 3.91% median: -3.90% win: 33% σ: 16.59% n: 3 2023-05-17 → 2026-07-31 |